IQ Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Not a good buy right now for an impatient trader: price is in a clear downtrend (bearish MAs + weakening MACD) with no fresh catalyst/news support.", "Oversold conditions (RSI_6 ~28.6) and price sitting near S1 support (1.928) could allow a short-lived bounce, but the base trend is still bearish and statistical near-term edge is slightly negative (next-day model: ~60% chance of -0.62%).", "Earnings (QDEC 2025) on 2026-02-26 pre-market is the next real catalyst; until then, upside likely relies on technical mean-reversion rather than improving fundamentals.", "Intellectia Proprietary Trading Signals: No signal on given stock today."]
["Trend: Bearish structure with SMA_200 > SMA_20 > SMA_5 (downtrend intact).", "Momentum: MACD histogram -0.0102 and negatively expanding -> bearish momentum strengthening.", "RSI: RSI_6 at 28.612 suggests oversold/washed-out conditions (near-term bounce possible), but not a confirmed reversal by itself.", "Key levels: Support S1=1.928 (very close to pre-market), then S2=1.858. Resistance Pivot=2.043, then R1=2.157 and R2=2.227. A reclaim of ~2.04\u20132.16 is needed to improve the technical picture."]
near support (1.
can attract short-term mean-reversion buyers.", "Options market skew is strongly bullish (very low put/call ratios), which can support a bounce if spot price stabilizes above ~1.93.", "Upcoming earnings on 2026-02-26 (QDEC
could become a catalyst if guidance or margins surprise positively."]
["No news in the last week: lack of a fresh narrative/catalyst while the trend remains bearish.", "Bearish momentum is still building (MACD histogram negative and expanding) and moving averages are stacked bearishly.", "Event risk ahead: earnings (2026-02-26 pre-market) can create sharp downside if results/guidance disappoint, especially with high implied volatility already priced.", "No notable supportive flow signals: hedge funds and insiders are reported neutral; no recent Congress trading data available."]
["Latest reported quarter: 2025/Q3.", "Revenue: 6,682,385,000, down -7.77% YoY (top-line contraction).", "Net income: -248,932,000, down -208.51% YoY (loss widened materially).", "EPS: -0.04, down -233.33% YoY (profitability deteriorated).", "Gross margin: 18.19%, down -17.39% YoY (margin compression).", "Overall: fundamentals are weakening, which makes sustained rallies harder without a clear catalyst."]
["Most recent update provided (2025-11-19): Morgan Stanley cut price target to $2.10 from $2.30 and maintained Equal Weight.", "Analyst view summary: expects Q4 revenue to return to growth due to pipeline improvement, but anticipates higher content costs/opex to pressure margins.", "Wall Street pros: potential for revenue re-acceleration in Q4 and a mean-reversion bounce from depressed levels.", "Wall Street cons: cost/margin pressure remains the key overhang; recent target cut reinforces limited upside conviction near term."]
